Impact of standardized immunophenotyping and MRD monitoring on early mortality reduction in childhood leukemia: a step towards addressing healthcare disparities in vulnerable populations from Southern Mexico

Simple item page
dc.contributor.authorLaura Alfaro-Hernández
dc.contributor.authorDalia Ramírez-Ramírez
dc.contributor.authorRubí Romo‐Rodríguez
dc.contributor.authorKaren Ayala-Contreras
dc.contributor.authorÁngeles Del Campo-Martínez
dc.contributor.authorEnrique López‐Aguilar
dc.contributor.authorJanet Flores Lujano
dc.contributor.authorAldo Allende-López
dc.contributor.authorErika Alarcón-Ruiz
dc.contributor.authorMa. del Rocío Baños-Lara
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:01:03Z
dc.date.available2026-03-22T14:01:03Z
dc.date.issued2025
dc.descriptionCitaciones: 3
dc.description.abstractCentralized, standardized MRD monitoring at the CCCL was associated with a reduction in early mortality and improved one-year survival in children with B-ALL from a socioeconomically vulnerable population. These findings demonstrate the clinical value and feasibility of implementing MRD-informed response assessment in LMICs and highlight the potential of centralized diagnostic platforms to reduce survival disparities in childhood leukemia.
dc.identifier.doi10.3389/fonc.2025.1614445
dc.identifier.urihttps://doi.org/10.3389/fonc.2025.1614445
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/44056
dc.language.isoen
dc.publisherFrontiers Media
dc.relation.ispartofFrontiers in Oncology
dc.sourceMexican Social Security Institute
dc.subjectMedicine
dc.subjectImmunophenotyping
dc.subjectHazard ratio
dc.subjectMinimal residual disease
dc.subjectConfidence interval
dc.subjectInternal medicine
dc.subjectPediatrics
dc.titleImpact of standardized immunophenotyping and MRD monitoring on early mortality reduction in childhood leukemia: a step towards addressing healthcare disparities in vulnerable populations from Southern Mexico
dc.typearticle

Files

Collections

Artículo Científico Publicado